ARCHIVES

Gleevec Approval Sets Record For FDA Review: 73 Days

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

Hilton Head, SC, Physician’s Files Subpoenaed By FBI

March 18, 1994

Blinatumomab Demonstrates High Response Rate in ALL

June 29, 2012

Needed Enhancement Or Unfunded Mandate? New NCI Program To Merge CCOP, NCCCP

July 13, 2012

Bill Introduced To Curb NIH Use Of Title 42 Salaries

August 10, 2012

32% Rise In Breast Cancer Diagnosis In 1980s Explained By Increase In Mammography Screening

September 21, 1990